[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100613993":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":36,"centralContacts":41,"locations":51,"responsibleParty":69,"collaborators":73,"id":76,"slug":77,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":28,"eligibilityCriteria":82,"healthyVolunteers":78,"sex":83,"minAge":84,"maxAge":46,"enrollmentInfo":85,"targetDuration":46,"studyType":88,"phases":89,"briefSummary":91,"conditions":92,"keywords":100,"overallStatus":54,"whyStopped":46,"lastUpdateSubmitDate":114,"lastUpdatePostDateStruct":115,"startDateStruct":118,"completionDateStruct":120,"leadSponsor":122,"locationsCount":123},{"fullName":5,"class":6},"University of Baghdad","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"AI-Based Mobile Application Plus Usual Care","EXPERIMENTAL","Participants in this group will receive the AI-based mobile application in addition to usual oncology care.\n\nThe Arabic-language mobile app uses artificial intelligence (AI) to provide personalized chemotherapy support, including symptom monitoring, medication adherence reminders, and educational guidance.\n\nParticipants will use the app daily for 12 weeks during their chemotherapy cycles.\n\nAll AI-generated advice is reviewed by oncologists and pharmacists to ensure clinical safety.\n\nThey will also receive standard oncology care provided by the hospital team, including chemotherapy administration, routine follow-up, and patient education according to local protocols.",[13,14],"Behavioral: AI-Based Mobile Application for Personalized Chemotherapy Support","Other: Usual Care",{"label":16,"type":17,"description":18,"interventionNames":19},"Usual Care Only","ACTIVE_COMPARATOR","Participants in this group will receive standard oncology care provided by the hospital team, including chemotherapy administration, routine follow-up, and patient education according to local protocols.\n\nThey will not have access to the AI-based mobile application.",[14],[21,29],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BEHAVIORAL","AI-Based Mobile Application for Personalized Chemotherapy Support","The intervention is an Arabic-language mobile application powered by artificial intelligence (AI) designed to provide personalized chemotherapy support for women with breast cancer.\n\nThe app assists participants by monitoring symptoms, sending medication adherence reminders, and offering educational content on managing side effects and improving treatment understanding.\n\nIt uses a conversational interface based on natural language processing (NLP) to communicate with users.\n\nParticipants are asked to use the app daily for 12 weeks while receiving chemotherapy.\n\nA human-in-the-loop system ensures oncologists and pharmacists review AI-generated advice for accuracy and safety.",[9],[27,28],"AI Breast Cancer Support App","AI-ChemoApp",{"type":6,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"Usual Care","Standard oncology care provided by the hospital team, including chemotherapy administration, routine follow-up, and patient education according to local protocols.",[9,16],[34,35],"ordinary care","standard care",[37],{"name":38,"affiliation":39,"role":40},"Samer Imad Mohammed, Assistant Prof","University of Baghdad-College of Pharmacy","PRINCIPAL_INVESTIGATOR",[42,48],{"name":43,"role":44,"phone":45,"phoneExt":46,"email":47},"Dena A. Al-Tameemi, MSc.","CONTACT","+9647901572647",null,"dina.abbas2400p@copharm.uobaghdad.edu.iq",{"name":49,"role":44,"phone":46,"phoneExt":46,"email":50},"Samer Imad Mohammed, PhD","Samer.jameel@copharm.uobag",[52],{"facility":53,"status":54,"city":55,"state":46,"zip":46,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":64},"Oncology Teaching Hospital-Medical City- Baghdad","RECRUITING","Baghdad","Iraq","IQ",{"type":59,"coordinates":60},"Point",[61,62],44.40088,33.34058,{"lat":62,"lon":61},[65],{"name":66,"role":44,"phone":67,"phoneExt":46,"email":68},"Rasha Saer Abbood, F.I.B.M.S med.oncology","009647813281259","Drrasha85@yahoo.com",{"type":70,"investigatorFullName":71,"investigatorTitle":72,"investigatorAffiliation":5,"oldNameTitle":46,"oldOrganization":46},"SPONSOR_INVESTIGATOR","Dena h. Al-Tameemi","Principal Investigator, University of Baghdad",[74],{"name":75,"class":6},"Baghdad Medical City","100613993","evaluating-an-ai-based-mobile-application-for-chemotherapy-support-in-breast-cancer-patients-100613993",false,"NCT07273812","Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients","Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Confirmed diagnosis of breast cancer stages I, II, or III.\n* Patients must be currently scheduled to initiate their first-ever cycle of chemotherapy.\n* Age 18 years or older.\n* Ability to understand and provide informed consent.\n* Possession of a smartphone (Android or iOS) and functional digital literacy, defined as the ability to independently navigate mobile applications, read on-screen text in Arabic, and input daily health data. (for the intervention group).\n* Willingness to comply with study procedures and follow-up schedules.\n* Ability to communicate in Arabic, as the mobile application and chatbot will be developed in Arabic.\n\nExclusion Criteria:\n\n* Patients with Stage IV (Metastatic) breast cancer.\n* Patients receiving concurrent hormonal therapy during the chemotherapy phase, to isolate chemotherapy-induced adverse events.\n\nPatients with cognitive impairment or severe psychiatric disorders that would preclude effective interaction with the mobile application or questionnaire completion.\n\n* Patients receiving palliative care where symptom management is the sole focus and active chemotherapy is not being administered with curative or life prolonging intent.\n* Patients participating in other interventional clinical trials that might confound the outcomes of this study.\n* Patients with severe comorbidities that could significantly impact their ability to participate or bias outcome measures.","FEMALE","18 Years",{"count":86,"type":87},130,"ESTIMATED","INTERVENTIONAL",[90],"NA","The goal of this clinical trial is to learn if an Arabic-language mobile application that uses artificial intelligence (AI) can help women with breast cancer during chemotherapy. The app is designed to give personalized support by reminding participants about their medications, teaching them how to manage treatment side effects, and alerting their healthcare team about serious symptoms.\n\nThe main questions this study aims to answer are:\n\n1. Does the AI-based mobile app provide accurate and safe recommendations for the patients?\n2. Does using the AI-based mobile app help lower treatment-related symptoms and side effects compared to usual care?\n3. Does the app help participants take their medications more regularly?\n4. Does it increase participants' understanding and satisfaction with the information they receive about their treatment?\n\nResearchers will compare two groups:\n\nGroup 1: Participants who use the AI-based mobile app plus usual oncology care. Group 2: Participants who receive usual care only.\n\nParticipants will:\n\n1. Use the mobile app daily for 12 weeks while receiving chemotherapy.\n2. Complete short questionnaires about symptoms, medication use, and quality of life at the start and end of the study.\n3. Report any problems or feedback about using the app. The AI app is for support and education only. It does not make treatment decisions. All information from the app will be reviewed by oncologists and pharmacists to ensure participant safety.",[93,94,95,96,97,98,99],"Breast Cancer","Breast Neoplasm","Chemotherapy-Related Toxicities","Medication Adherence","Quality of Life in Cancer Patients","Accuracy of AI App","Symptom Management",[101,102,103,104,105,106,107,108,109,110,111,112,113],"Artificial Intelligence","Mobile Application","digital health","supportive care","chemotherapy","patient education","Symptom Monitoring","Human-in-the-Loop AI","Breast Cancer Chemotherapy","Oncology","Arabic Language App","Pharmacy Iraq","Randomized Controlled Trial","2026-06-10",{"date":116,"type":117},"2026-06-12","ACTUAL",{"date":119,"type":117},"2026-06-01",{"date":121,"type":87},"2026-11-06",{"name":71,"class":6},1]